Autoimmunology

G.J. Giudice, D.J. Emery, L.A. Diaz, "Cloning and primary structural analysis of the bullous pemphigoid autoantigen, BP180," Journal of Investigative Dermatology, 99:243-50, 1992. George J. Giudice (Departments of Dermatology and Biochemistry, Medical College of Wisconsin, Milwaukee): "Our investigation of an autoimmune skin disease has uncovered a novel protein that may function in cell-matrix adhesion. The disease, bullous pemphi

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

G.J. Giudice, D.J. Emery, L.A. Diaz, "Cloning and primary structural analysis of the bullous pemphigoid autoantigen, BP180," Journal of Investigative Dermatology, 99:243-50, 1992.

George J. Giudice (Departments of Dermatology and Biochemistry, Medical College of Wisconsin, Milwaukee): "Our investigation of an autoimmune skin disease has uncovered a novel protein that may function in cell-matrix adhesion. The disease, bullous pemphigoid, is characterized by a blistering of the skin due to a detachment of the epithelium from the connective tissue layer, and by the production of autoantibodies directed against the cutaneous basement membrane zone. In an attempt to identify and characterize self antigens associated with this disease, we screened a cDNA expression library with serum from a bullous pemphigoid patient. In this way we cloned a novel epidermal protein, BP180, which localizes to the hemidesmosome, a cellular structure involved in anchoring basal epithelial cells to the basement membrane.

"Our analysis revealed that BP180 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies